[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100523051":3},{"organization":4,"armGroups":7,"interventions":33,"overallOfficials":38,"centralContacts":63,"locations":71,"responsibleParty":86,"collaborators":10,"id":89,"slug":90,"hasResults":91,"nctId":92,"briefTitle":93,"officialTitle":94,"acronym":95,"eligibilityCriteria":96,"healthyVolunteers":91,"sex":97,"minAge":98,"maxAge":10,"enrollmentInfo":99,"targetDuration":102,"studyType":103,"phases":10,"briefSummary":104,"conditions":105,"keywords":110,"overallStatus":73,"whyStopped":10,"lastUpdateSubmitDate":119,"lastUpdatePostDateStruct":120,"startDateStruct":123,"completionDateStruct":125,"leadSponsor":127,"locationsCount":128},{"fullName":5,"class":6},"University Hospital Dubrava","OTHER",[8,14,18,22,26,30],{"label":9,"type":10,"description":11,"interventionNames":12},"Acute coronary syndrome - ACS",null,"patients who were diagnosed with acute coronary syndrome: STEMI, non-STE ACS - NSTEMI and unstable angina, who underwent coronary angiography and were prescribed with optimal medicament therapy",[13],"Other: SGLT-2 inh therapy, CIED implantation, thromboaspiration,",{"label":15,"type":10,"description":16,"interventionNames":17},"Transcatheter aortic valve implantation - TAVI","patients with aortic stenosis who underwent transcatheter percotaneous implantation of the arteficial aortic valve",[13],{"label":19,"type":10,"description":20,"interventionNames":21},"Venous thromboembolism - VTE","patients with pulmonary embolism and deep vein thrombosis, with a focus on those who underwent thromboaspiration due to high or medium-high risk pulmonary embolism",[13],{"label":23,"type":10,"description":24,"interventionNames":25},"Heart failure with SGLT2 inhibitor therapy included - HF-SGLT2","patients with heart failure with reduced, mid-reduced and preserved systolic function who were prescribed with a SGLT-2 inhibitor therapy, and other optimal medicament therapy for HF",[13],{"label":27,"type":10,"description":28,"interventionNames":29},"Cardiac implantable electronic device - CIED","patients who were implanted with a cardiac implantable electronic device: pacemaker, conduction system pacing device, cardioverter-defibrilator or cardiac resynchronization therapy with or without defibrilator option",[13],{"label":31,"type":10,"description":32,"interventionNames":10},"Arrhythmias","patients who underwent electrophysiology study, including PVI for atrial fibrillation, as well as SVT ablations, and ventricular arrhythmia ablation (both premature ventriclar beats and ventricular tachycardia ablation in ischsmic and non-ischemic cardiomyopathy).",[34],{"type":6,"name":35,"description":36,"armGroupLabels":37,"otherNames":10},"SGLT-2 inh therapy, CIED implantation, thromboaspiration,","long-term follow up and observation of patients treated in Cardiology department in the tertiary center and University hospital",[9,27,23,15,19],[39,43,46,48,50,52,54,56,58,60],{"name":40,"affiliation":41,"role":42},"Ivana Jurin, M.D.","Dubrava University Hospital","STUDY_CHAIR",{"name":44,"affiliation":41,"role":45},"Irzal Hadzibegovic, M.D.","PRINCIPAL_INVESTIGATOR",{"name":47,"affiliation":41,"role":45},"Nikola Pavlovic, M.D.",{"name":49,"affiliation":41,"role":45},"Marin Pavlov, M.D.",{"name":51,"affiliation":41,"role":45},"Mario Udovicic, M.D.",{"name":53,"affiliation":41,"role":45},"Danijel Unic, M.D.",{"name":55,"affiliation":41,"role":45},"Ana Jordan, M.D.",{"name":57,"affiliation":41,"role":45},"Tomislav Sipic, M.D.",{"name":59,"affiliation":41,"role":45},"Diana Rudan, M.D.",{"name":61,"affiliation":41,"role":62},"Sime Manola, M.D.","STUDY_DIRECTOR",[64,69],{"name":65,"role":66,"phone":67,"phoneExt":10,"email":68},"Ivan Zeljkovic, M.D.","CONTACT","00385917823289","kardio@kbd.hr",{"name":40,"role":66,"phone":10,"phoneExt":10,"email":70},"ivanajurin1912@gmail.com",[72],{"facility":41,"status":73,"city":74,"state":10,"zip":75,"country":76,"countryCode":77,"cosmosGeoPoint":78,"geoPoint":83,"contacts":84},"RECRUITING","Zagreb","10000","Croatia","HR",{"type":79,"coordinates":80},"Point",[81,82],15.97798,45.81444,{"lat":82,"lon":81},[85],{"name":61,"role":66,"phone":10,"phoneExt":10,"email":68},{"type":45,"investigatorFullName":87,"investigatorTitle":88,"investigatorAffiliation":5,"oldNameTitle":10,"oldOrganization":10},"Ivan Zeljkovic","M.D., Ph.D., Associate Professor","100523051","cardiology-research-dubrava-prospective-registry-100523051",false,"NCT06090591","Cardiology Research Dubrava Prospective Registry","Cardiology Research Dubrava: Single Centre, Prospective Registry","CaRDr","Inclusion Criteria: patients implanted with CIED, or with VTE, or with ACS or with TAVI -\n\nExclusion Criteria: non compliance, not undergoing follow-up at this center\n\n\\-","ALL","18 Years",{"count":100,"type":101},3000,"ESTIMATED","10 Years","OBSERVATIONAL","Cardiology Research Dubrava registry is a prospective, single centre registry including patients with acute coronary syndrome with and without ST segment elevation, patients with heart failure who were prescribed with SGLT-2 inhibitors, patients implanted with TAVI, patients with venous thromboembolism, patients with pulmonary embolism who underwent thromboaspiration procedure, patients implanted with ICD, CRT and conduction system pacing devices, as well as patients with atrial fibrillation who underwent pulmonary vein isolation and are prescribed with long-term anticoagulation therapy.",[106,107,108,109],"Heart Failure","Arrhythmias, Cardiac","Atrial Fibrillation","Acute Coronary Syndrome",[111,112,113,114,115,116,117,118],"chronic heart failure","acute coronary syndrome","SGLT-2 inhibitors","anticoagulants","atrial fibrillation","NTproBNP","cardiac implanted electronic device","observationl","2024-03-15",{"date":121,"type":122},"2024-03-19","ACTUAL",{"date":124,"type":122},"2023-01-01",{"date":126,"type":101},"2033-06",{"name":5,"class":6},1]